The etiology and prognosis of chronic daily headache (CDH) are not well understood. The aim of this study is to describe factors that predict CDH onset or remission in an adult population. Potential cases (180 þ headaches per year, n ¼ 1134) and controls (two to 104 headaches per year, n ¼ 798) were interviewed two times over an average 11 months of follow-up. Factors associated with CDH prevalence at baseline were evaluated. The incidence of CDH and risk factors for onset were assessed in controls whose headache frequency increased to 180 þ per year at follow-up. Prognostic factors were assessed in CDH cases whose headache frequency fell at follow-up.
Introduction
About 4% of the adult population experiences headache 15 days per month or more (chronic daily headache) (Scher et al., 1998; Castillo et al., 1999; Wang et al., 2000; Hagen et al., 2000; Prencipe et al., 2001; Lu et al., 2001; Lanteri-Minet et al., 2003) . The two most prevalent types of primary chronic daily headache (CDH), equally represented in population samples, are chronic tension-type headache and chronic migraine (also known as transformed migraine) (Scher et al., 1998; Castillo et al., 1999; Wang et al., 2000; Prencipe et al., 2001; Lu et al., 2001) . Although the etiology of CDH is uncertain, demographic risk factors identified in earlier studies include female gender and lower educational level.
There are limited data on the natural course of CDH in clinical or population samples although there are a number of studies describing the efficacy of various inpatient and outpatient regimens for CDH (Baumgartner et al., 1989; Lake et al., 1993; Pini et al., 1996; Schnider et al., 1996; Pringsheim and Howse, 1998; Zed et al., 1999; Krymchantowski and Barbosa, 2000; Linton-Dahlof et al., 2000; Lu et al., 2000) . With aggressive treatment, including inpatient medication withdrawal and other interventions, about half of CDH patients in specialty care remit to less than 15 headaches days per month.
